Evgen Pharma Says SFX-01 To Be Evaluated In Covid-19 Trial
17 Junho 2020 - 06:42AM
Alliance News
Evgen Pharma PLC
on Wednesday said its SFX-01 product has been selected to be
evaluated in a Phase II/III trial to in ...
Subscribe now to see this Premium News
article from
Alliance News Professional covers every UK
stock in your portfolio. It goes beyond regulatory news and free
web services to give your investment decisions an edge over the
crowd.
- In The
Know - Management and analyst comments that go beyond company
announcements.
- Flash headlines on all 2,400 London-listed companies before the
news hits the open web.
- Broker Ratings - The
earliest tip-offs, many before the market opens.
- Economic data and central bank flashes from UK, US and
eurozone.
- Taking
AIM - Up to the minute market commentary on AIM stocks.
- Over 500 news items per trading day for just £39.60 per month,
and cancel at any time.
Call us on +44 (0) 203 8794 460 to get
started.
Evgen Pharma (LSE:EVG)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Evgen Pharma (LSE:EVG)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024